Dennis Williams, P.C.

Healthcare Providers

• VSP Vision in its acquisition of Eyemart Express, a provider of eye care services and eyewear, from FFL Partners and Leonard Green & Partners
• Waud Capital Partners in its acquisition of Senior Helpers, a provider home care and wellness services for seniors, from Advocate Health
• GTCR, alongside Avryo Health Services, in its investment in 7to7 Dental, a dental service organization
• Silver Oak backed-Integrated Oncology Network, a provider of oncology services, in its pending $1.115 billion sale to Cardinal Health (NYSE: CAH)
• Monarch Alternative Capital-backed Shopko Optical, an optical retailer and provider of optometric services, in its $290 million sale to Fielmann Group (XETRA: FIE)
• TowerBrook Capital Partners in its acquisition of Maxor National Pharmacy Services, a provider of pharmacy and healthcare services, including retail and mail order prescriptions, pharmacy benefits management, pharmacy consulting and infusion and injection services, from Beecken Petty O’Keefe & Company
• L Catterton in its $680 million acquisition of Thorne HealthTech (Nasdaq: THRN), a provider of health and wellness solutions
• TPG's The Rise Fund in its investment in Banyan Treatment Centers, a provider of substance use disorder and mental health services
• Brookfield Special Investments in its $400 million investment in Sono Bello, a provider of laser liposuction and body contouring
• Brookfield-backed Everise, a healthcare services outsourcing company, in its investment from Warburg Pincus, valuing the company at $1 billion
• Oak Street Health (NYSE: OSH), a primary care company, in its $10.6 billion sale to CVS Health (NYSE: CVS)
• Charlesbank Capital Partners in its acquisition of Action Behavior Centers, a provider of Applied Behavior Analysis therapy, from NexPhase Capital

Healthcare Technology

• Knox Lane in its acquisition of All Star Healthcare Solutions, a healthcare staffing firm focused on the locum tenens market
• General Catalyst-backed Commure in its $139 million acquisition of Augmedix (Nasdaq: AUGX), a provider of ambient AI medical documentation and solutions
• Vista Equity Partners in its $1.25 billion acquisition of Model N (NYSE: MODN), a provider of revenue optimization and compliance
• Apptio, a portfolio company of Vista Equity Partners, in its acquisition of Cloudability, a cloud cost management software solutions provider
• Altaris in its pending $540 million acquisition of Sharecare (Nasdaq: SHCR), a provider of a digital healthcare platform
• Blackstone in its investment in Chartis, a provider of healthcare advisory services
• TA Associates in its investment in Solarity, a provider of automated clinical data processing solutions
• Francisco Partners-backed QGenda, a provider of healthcare workforce management software solutions, in its sale to Hearst Health
• Olympus Partners in the sale of Soliant, a provider of workforce solutions in K-12 school districts and healthcare facilities, to The Vistria Group
• MultiPlan Corp. (NYSE: MPLN) in its $160 million acquisition of Benefits Science, a data and advanced analytics company
• Alpine Investors in its acquisition of Medusind, a provider of revenue cycle management services to the healthcare industry, from H.I.G. Capital
• TA Associates-backed Alpha II in its acquisition of RCxRules, a provider of healthcare revenue cycle automation
• Warburg Pincus in its investment in ParetoHealth, a provider of an employee benefits platform
• Thomas H. Lee Partners-backed Nextech, a provider of clinical and administrative healthcare technology solutions, in its $1.4 billion sale to TPG
• Thoma Bravo-backed Zipari, a provider of healthcare consumer experience technology, in its sale to mPulse
  

Life Sciences

• KalVista Pharmaceuticals (Nasdaq: KALV), a provider of oral therapies for individuals affected by rare diseases, in its pending $1.9 billion sale to Chiesi
• Eli Lilly and Company (NYSE: LLY) in its pending $7 billion acquisition of Kelonia Therapeutics, a clinical-stage biotechnology company
• Ajax Therapeutics, a biopharmaceutical company, in its pending $2.3 billion sale to Eli Lilly (NYSE: LLY)
• Kimberly-Clark Corp. (Nasdaq: KMB) in its pending $48.7 billion acquisition of Kenvue (NYSE: KVUE), a global consumer health company
• Ingersoll Rand (NYSE: IR) in its $2.325 billion acquisition of ILC Dover, a provider of solutions for biopharmaceutical, pharmaceutical and medical device markets, from New Mountain Capital
• Owens & Minor (NYSE: OMI) in its proposed $1.36 billion acquisition of Rotech Healthcare, a provider of home medical equipment
• Carlisle Companies (NYSE: CSL) in its $2.025 billion sale of Carlisle Interconnect Technologies, a provider of high-performance wire and cable, to Amphenol (NYSE: APH)
• GTCR in its $627 million acquisition of Surmodics (Nasdaq: SRDX), a provider of medical device and in vitro diagnostic technologies
• Peak Rock Capital in its $787.5 million acquisition of HuFriedyGroup, a provider of instruments, infection prevention products, instrument management systems and conscious sedation products for the dental industry, from STERIS (NYSE:STE)
• CapVest Partners-backed Calyx in its $115 million acquisition of Invicro, a provider of imaging biomarker services, from REALM IDx
• Montagu Private Equity in its $700 million acquisition of the Medical Device Components business from Johnson Matthey (LSE: JMAT)
• THL Partners in its investment in Red Nucleus, a provider of strategic services across the entire life sciences product cycle
• Francisco Partners in the investment in RedSail Technologies, a provider of pharmacy technology and solutions, from Leonard Green & Partners
• GTCR-backed Maravai LifeSciences (Nasdaq: MRVI) in its acquisition of Alphazyme, an OEM provider of custom, scalable molecular biology enzymes
• Bansk Group-backed Arcadia Consumer Healthcare in its $397 million acquisition of Avrio Health, a provider of consumer health products, from Purdue Pharma
• Waud Capital Partners-backed PharmAlliance in its acquisition of Biobridges, a drug development consulting business, from Soliant Health
• AbbVie (NYSE: ABBV) in its $8.7 billion acquisition of Cerevel Therapeutics (Nasdaq: CERE), a neuroscience drug company
• Thomas H. Lee Partners-backed IMO in its acquisition of Melax Technologies, a provider of natural language processing technology used to extract key information from biomedical textual data
• Eli Lilly and Company (NYSE: LLY) in its $1.925 billion acquisition of Versanis Bio, a clinical-stage biopharmaceutical company
• FFL Partners in its investment in Johnson County Clin-Trials, a clinical research site platform serving pharmaceutical and biotechnology companies and contract research organizations

Before joining Kirkland, Dennis was a partner at DLA Piper.